OpenEvidence: When the Answer Matters

Can artificial intelligence help physicians make better clinical decisions—and what evidence would demonstrate that it does?

Medicine has an information problem.

The volume of medical research continues to grow, while physicians must make consequential decisions with limited time and incomplete information. Finding the right evidence, interpreting it correctly, and determining whether it applies to an individual patient are distinct challenges.

Artificial intelligence offers an intriguing possibility: making medical knowledge more accessible when it is needed.

OpenEvidence is among the companies pursuing that possibility. Its platform helps physicians search medical literature, explore clinical questions, and examine cited sources.

The promise is substantial. So is the responsibility.

Access Is Not the Same as Understanding

Imagine a physician confronting an unfamiliar diagnosis or evaluating competing treatments.

An AI system that identifies relevant research in seconds could be enormously useful. It might uncover evidence the physician would otherwise miss, help compare alternatives, or bring a recently published finding into consideration.

But finding information is only the beginning.

A medical citation can be authentic without supporting the conclusion attached to it. A study can be methodologically sound without applying to the patient in question. A recommendation can be consistent with published guidance while overlooking an important clinical exception.

These distinctions are not arguments against AI. They describe the work that remains after information retrieval.

The question is not simply whether OpenEvidence can find credible sources.

It is whether access to those sources improves the decisions that follow.

What Should We Measure?

Much of the discussion surrounding clinical AI focuses on accuracy, speed, and the quality of generated answers.

Those are legitimate measures. They are not necessarily the measures that matter most.

Consider three possibilities.

An AI system might provide a correct answer that confirms a physician's existing judgment. It might provide new information that improves a treatment decision. Or it might deliver a persuasive but incomplete answer that leads to an inappropriate decision.

Each interaction could appear successful by some measures. Their consequences would be quite different.

That is why evaluating clinical AI requires more than asking whether its answers are accurate.

We should also ask whether physicians recognize errors, whether the system changes decisions, whether those changes are appropriate, and ultimately whether patients benefit.

A faster answer is valuable. A better decision is more consequential.

The Physician Is Part of the Evidence

There is a familiar response to concerns about medical AI: keep a physician in the loop.

That may be sensible, but it is not a complete safety argument.

Physicians bring clinical experience, patient knowledge, professional judgment, and accountability. They can identify contradictions, recognize exceptions, and place published evidence in context.

They can also make mistakes.

Time pressure, incomplete information, cognitive bias, and misplaced confidence are not exclusive to artificial intelligence.

Combining a physician with AI does not automatically produce better results than either could achieve independently.

The relevant comparison is empirical.

For a particular clinical task, how does physician judgment perform without AI? How does the AI perform under comparable conditions? And what happens when they work together?

Where does the combination improve performance? Where does it introduce new risks?

The answers may vary by specialty, patient population, clinical setting, and the decision being made.

We should not presume that the human is always superior. Neither should we presume that adding AI necessarily improves the human.

Both propositions must earn their place in the evidence.

From Information to Authority

Another distinction is worth making: helping someone find evidence is not the same as authorizing a clinical decision.

An AI system may be well suited to locating research, summarizing findings, or identifying questions that deserve further investigation.

Those capabilities do not automatically establish that it should recommend a treatment, make a diagnosis independently, or initiate clinical action.

Each additional responsibility carries different consequences.

The evidence required should therefore reflect not only the system's technical performance, but also the authority being granted to it.

A tool that helps a physician locate a study operates within a different risk environment from one that independently determines a course of treatment.

And a system that performs well in one clinical setting may not perform equally well in another.

The appropriate boundaries should follow demonstrated performance, not technological enthusiasm or professional tradition.

The Larger Decision System

Perhaps the most important lesson from OpenEvidence is that the AI cannot be evaluated entirely in isolation.

The consequential system includes the medical literature available to it, the quality of the physician's question, the information supplied about the patient, the AI's retrieval and synthesis, the physician's interpretation, and the clinical action ultimately taken.

A component can perform exactly as designed while the larger system produces an undesirable result.

Conversely, an imperfect component may improve the overall system if it reliably addresses a more consequential weakness.

That is why the evaluation should extend beyond the product.

What decision is being improved? Compared with what alternative? Under which conditions? With what evidence? And how will we know when the arrangement needs to change?

Those questions matter whether a physician, an AI system, or a combination of the two performs the work.

What the Evidence Must Ultimately Show

OpenEvidence represents a meaningful effort to make medical knowledge more accessible to practicing physicians.

That is a valuable objective.

But access to information, confidence in an answer, improved clinical judgment, and improved patient outcomes are different propositions.

Evidence supporting one does not automatically establish the others.

The strongest case for clinical AI will come from demonstrating where it improves consequential decisions, identifying where it does not, and establishing safeguards proportionate to the risks.

That requires testing real alternatives, examining failures as carefully as successes, and revisiting conclusions as new evidence emerges.

The goal is not to protect human judgment from competition or to give artificial intelligence the benefit of the doubt.

It is to discover which arrangements produce better care.

If AI can put more medical information within reach, what will it take to put better health care within reach, too?

Further Reading

1. Reference quality of OpenEvidence across five medical specialties — npj Health Systems, September 2, 2026. Examines 4,979 citations, but does not determine whether they support the clinical conclusions.

2. OpenEvidence clinical question-answering platform: systematic review of early evaluations — npj Digital Medicine, August 12, 2026. Reviews 11 studies and identifies both strengths and limitations.

3. General-purpose large language models outperform specialized clinical AI tools on medical benchmarks — Nature Medicine, June 12, 2026. Compares performance on medical benchmarks, not actual patient outcomes.